The current clinical development model is shifting toward a generative AI-augmented proactive approach supported by real-world data for real time evidence.
Dave Li, MD, PhD; and Anna Baran, MD
Advertisement
Articles by Dave Li, MD, PhD; and Anna Baran, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
2
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
3
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
4
ACT Brief Weekly Recap: AI Innovation, Industry Resilience, and Supply Chain Readiness
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
